Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy. (2023)
Attributed to:
Supercharged protein-surfactant bioconjugates for next-generation cell therapies
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s13346-023-01362-3
PubMed Identifier: 37301780
Publication URI: http://europepmc.org/abstract/MED/37301780
Type: Journal Article/Review
Volume: 13
Parent Publication: Drug delivery and translational research
Issue: 11
ISSN: 2190-393X